• Je něco špatně v tomto záznamu ?

Molecular mechanism for the action of the anti-CD44 monoclonal antibody MEM-85

J. Škerlová, V. Král, M. Kachala, M. Fábry, L. Bumba, DI. Svergun, Z. Tošner, V. Veverka, P. Řezáčová,

. 2015 ; 191 (2) : 214-23. [pub] 20150609

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16020688

The hyaluronate receptor CD44 plays role in cell adhesion and migration and is involved in tumor metastasis. The extracellular domain of CD44 comprises the hyaluronate-binding domain (HABD) and the membrane-proximal stem region; the short intracellular portion interacts with adaptor proteins and triggers signaling pathways. Binding of hyaluronate to CD44 HABD induces an allosteric conformational change, which results in CD44 shedding. A poorly characterized epitope in human CD44 HABD is recognized by the murine monoclonal antibody MEM-85, which cross-blocks hyaluronate binding to CD44 and also induces CD44 shedding. MEM-85 is of therapeutic interest, as it inhibits growth of lung cancer cells in murine models. In this work, we employed a combination of biophysical methods to determine the MEM-85 binding epitope in CD44 HABD and to provide detailed insight into the mechanism of MEM-85 action. In particular, we constructed a single-chain variable fragment (scFv) of MEM-85 as a tool for detailed characterization of the CD44 HABD-antibody complex and identified residues within CD44 HABD involved in the interaction with scFv MEM-85 by NMR spectroscopy and mutational analysis. In addition, we built a rigid body model of the CD44 HABD-scFv MEM-85 complex using a low-resolution structure obtained by small-angle X-ray scattering. The MEM-85 epitope is situated in the C-terminal part of CD44 HABD, rather than the hyaluronate-binding groove, and the binding of MEM-85 induces a structural reorganization similar to that induced by hyaluronate. Therefore, the mechanism of MEM-85 cross-blocking of hyaluronate binding is likely of an allosteric, relay-like nature.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020688
003      
CZ-PrNML
005      
20160801105851.0
007      
ta
008      
160722s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jsb.2015.06.005 $2 doi
024    7_
$a 10.1016/j.jsb.2015.06.005 $2 doi
035    __
$a (PubMed)26066970
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Škerlová, Jana $u Institute of Organic Chemistry and Biochemistry, AS CR, v.v.i., Flemingovo nam. 2, Prague 6, 166 10, Czech Republic; Institute of Molecular Genetics, AS CR, v.v.i., Videnska 1083, Prague 4, 142 20, Czech Republic; Department of Biochemistry, Faculty of Science, Charles University in Prague, Albertov 6, Prague 2, 128 40, Czech Republic.
245    10
$a Molecular mechanism for the action of the anti-CD44 monoclonal antibody MEM-85 / $c J. Škerlová, V. Král, M. Kachala, M. Fábry, L. Bumba, DI. Svergun, Z. Tošner, V. Veverka, P. Řezáčová,
520    9_
$a The hyaluronate receptor CD44 plays role in cell adhesion and migration and is involved in tumor metastasis. The extracellular domain of CD44 comprises the hyaluronate-binding domain (HABD) and the membrane-proximal stem region; the short intracellular portion interacts with adaptor proteins and triggers signaling pathways. Binding of hyaluronate to CD44 HABD induces an allosteric conformational change, which results in CD44 shedding. A poorly characterized epitope in human CD44 HABD is recognized by the murine monoclonal antibody MEM-85, which cross-blocks hyaluronate binding to CD44 and also induces CD44 shedding. MEM-85 is of therapeutic interest, as it inhibits growth of lung cancer cells in murine models. In this work, we employed a combination of biophysical methods to determine the MEM-85 binding epitope in CD44 HABD and to provide detailed insight into the mechanism of MEM-85 action. In particular, we constructed a single-chain variable fragment (scFv) of MEM-85 as a tool for detailed characterization of the CD44 HABD-antibody complex and identified residues within CD44 HABD involved in the interaction with scFv MEM-85 by NMR spectroscopy and mutational analysis. In addition, we built a rigid body model of the CD44 HABD-scFv MEM-85 complex using a low-resolution structure obtained by small-angle X-ray scattering. The MEM-85 epitope is situated in the C-terminal part of CD44 HABD, rather than the hyaluronate-binding groove, and the binding of MEM-85 induces a structural reorganization similar to that induced by hyaluronate. Therefore, the mechanism of MEM-85 cross-blocking of hyaluronate binding is likely of an allosteric, relay-like nature.
650    _2
$a monoklonální protilátky $x chemie $7 D000911
650    _2
$a antigeny CD44 $x chemie $7 D018960
650    _2
$a vazebná místa $7 D001665
650    _2
$a mapování epitopu $7 D018604
650    _2
$a lidé $7 D006801
650    _2
$a kyselina hyaluronová $x chemie $7 D006820
650    _2
$a Jurkat buňky $7 D019169
650    _2
$a molekulární modely $7 D008958
650    _2
$a mutace $7 D009154
650    _2
$a nukleární magnetická rezonance biomolekulární $7 D019906
650    _2
$a terciární struktura proteinů $7 D017434
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Král, Vlastimil $u Institute of Molecular Genetics, AS CR, v.v.i., Videnska 1083, Prague 4, 142 20, Czech Republic.
700    1_
$a Kachala, Michael $u European Molecular Biology Laboratory, Hamburg Outstation, c/o Deutsches Elektronen-Synchrotron (DESY), Notkestrasse 85, D-22603 Hamburg, Germany.
700    1_
$a Fábry, Milan $u Institute of Molecular Genetics, AS CR, v.v.i., Videnska 1083, Prague 4, 142 20, Czech Republic.
700    1_
$a Bumba, Ladislav $u Institute of Microbiology, AS CR, v.v.i., Videnska 1083, Prague 4, 142 20, Czech Republic.
700    1_
$a Svergun, Dmitri I $u European Molecular Biology Laboratory, Hamburg Outstation, c/o Deutsches Elektronen-Synchrotron (DESY), Notkestrasse 85, D-22603 Hamburg, Germany.
700    1_
$a Tošner, Zdeněk $u Faculty of Science, Charles University in Prague, Albertov 6, Prague 2, 128 40, Czech Republic.
700    1_
$a Veverka, Václav $u Institute of Organic Chemistry and Biochemistry, AS CR, v.v.i., Flemingovo nam. 2, Prague 6, 166 10, Czech Republic. Electronic address: veverka@uochb.cas.cz.
700    1_
$a Řezáčová, Pavlína $u Institute of Organic Chemistry and Biochemistry, AS CR, v.v.i., Flemingovo nam. 2, Prague 6, 166 10, Czech Republic; Institute of Molecular Genetics, AS CR, v.v.i., Videnska 1083, Prague 4, 142 20, Czech Republic. Electronic address: rezacova@uochb.cas.cz.
773    0_
$w MED00002951 $t Journal of structural biology $x 1095-8657 $g Roč. 191, č. 2 (2015), s. 214-23
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26066970 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160801110119 $b ABA008
999    __
$a ok $b bmc $g 1155358 $s 945216
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 191 $c 2 $d 214-23 $e 20150609 $i 1095-8657 $m Journal of structural biology $n J Struct Biol $x MED00002951
LZP    __
$a Pubmed-20160722
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace